253
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Photodynamic Therapy with A Cationic Functionalized Fullerene Rescues Mice From Fatal Wound Infections

, , , , , , & show all
Pages 1525-1533 | Published online: 14 Dec 2010

Bibliography

  • Culotta L , KoshlandDE Jr: Buckyballs: wide open playing field for chemists. Science254(5039), 1706–1709 (1991).
  • Duncan LK , JinschekJR, VikeslandPJ: C60 colloid formation in aqueous systems: effects of preparation method on size, structure, and surface charge.Environ. Sci. Technol.42(1), 173–178 (2008).
  • Nakamura E , IsobeH: Functionalized fullerenes in water. The first 10 years of their chemistry, biology, and nanoscience.Acc. Chem. Res.36(11), 807–815 (2003).
  • Gharbi N , PressacM, HadchouelM, SzwarcH, WilsonSR, MoussaF: [60]fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity.Nano Lett.5(12), 2578–2585 (2005).
  • Zakharian TY , SeryshevA, SitharamanB, GilbertBE, KnightV, WilsonLJ: A fullerene-paclitaxel chemotherapeutic: synthesis, characterization, and study of biological activity in tissue culture.J. Am. Chem. Soc.127(36), 12508–12509 (2005).
  • Isobe H , NakanishiW, TomitaN, JinnoS, OkayamaH, NakamuraE: Nonviral gene delivery by tetraamino fullerene.Mol. Pharm.3(2), 124–134 (2006).
  • Sitharaman B , ZakharianTY, SarafAet al.: Water-soluble fullerene (c60) derivatives as nonviral gene-delivery vectors.Mol. Pharm.5(4), 567–578 (2008).
  • Mroz P , TegosGP, GaliH, WhartonT, SarnaT, HamblinMR: Photodynamic therapy with fullerenes.Photochem. Photobiol. Sci.6(11), 1139–1149 (2007).
  • Advances In Photodynamic Therapy: Basic, Translational and Clinical. Mroz P, Hamblin MR (Eds). Artech House, Norwood, MA, USA (2008).
  • Castano AP , DemidovaTN, HamblinMR: Mechanisms in photodynamic therapy: part one – photosensitizers, photochemistry and cellular localization.Photodiagn. Photodyn. Ther.1(4), 279–293 (2004).
  • Hamblin MR , HasanT: Photodynamic therapy: a new antimicrobial approach to infectious disease?Photochem. Photobiol. Sci.3(5), 436–450 (2004).
  • Jori G , FabrisC, SoncinMet al.: Photodynamic therapy in the treatment of microbial infections: basic principles and perspective applications.Lasers Surg. Med.38(5), 468–481 (2006).
  • Merchat M , SpikesJD, BertoloniG, JoriG: Studies on the mechanism of bacteria photosensitization by meso-substituted cationic porphyrins.J. Photochem. Photobiol. B35(3), 149–157 (1996).
  • Soukos NS , Ximenez-FyvieLA, HamblinMR, SocranskySS, HasanT: Targeted antimicrobial photochemotherapy.Antimicrob. Agents Chemother.42(10), 2595–2601 (1998).
  • Giuliani F , MartinelliM, CocchiA, ArbiaD, FantettiL, RoncucciG: In vitro resistance selection studies of rlp068/cl, a new Zn(II) phthalocyanine suitable for antimicrobial photodynamic therapy.Antimicrob. Agents Chemother.54(2), 637–642 (2010).
  • Minnock A , VernonDI, SchofieldJ, GriffithsJ, ParishJH, BrownSB: Mechanism of uptake of a cationic water-soluble pyridinium zinc phthalocyanine across the outer membrane of Escherichia coli.Antimicrob. Agents Chemother.44(3), 522–527 (2000).
  • Tegos GP , DemidovaTN, Arcila-LopezDet al.: Cationic fullerenes are effective and selective antimicrobial photosensitizers.Chem. Biol.12(10), 1127–1135 (2005).
  • Rosenthal SM : Local and systemic therapy of Pseudomonas septicemia in burned mice.Ann. Surg.165(1), 97–103 (1967).
  • Markley K , SmallmanE: Protection by vaccination against pseudomonas infection after thermal injury.J. Bacteriol.96(4), 867–874 (1968).
  • McManus AT , McLeodCG Jr, Mason AD Jr: Experimental Proteus mirabilis burn surface infection. Arch. Surg.117(2), 187–191 (1982).
  • Rocchetta HL , BoylanCJ, FoleyJWet al.: Validation of a noninvasive, real-time imaging technology using bioluminescent Escherichia coli in the neutropenic mouse thigh model of infection.Antimicrob. Agents Chemother.45(1), 129–137 (2001).
  • Demidova TN , HamblinMR: Effect of cell–photosensitizer binding and cell density on microbial photoinactivation.Antimicrob. Agents Chemother.49(6), 2329–2335 (2005).
  • Jett BD , HatterKL, HuyckeMM, GilmoreMS: Simplified agar plate method for quantifying viable bacteria.Biotechniques23(4), 648–650 (1997).
  • Hamblin MR , O‘DonnellDA, MurthyN, ContagCH, HasanT: Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging.Photochem. Photobiol.75(1), 51–57 (2002).
  • Kaplan EL , MeierP: Nonparametric estimation from incomplete observations.J. Am. Stat. Assoc.53, 457–448 (1958).
  • Peto R , PetoJ: Asymptotically efficient rank invariant test procedures.J. Royal Stat. Soc. A135, 185–207 (1972).
  • Dai T , HuangYY, HamblinMR: Photodynamic therapy for localized infections – state of the art.Photodiagnosis Photodyn. Ther.6(3–4), 170–188 (2009).
  • Schito GC : Is antimicrobial resistance also subject to globalization?Clin. Microbiol. Infect.8(Suppl. 3), 1–8; discussion 33–35 (2002).
  • Maisch T , BaierJ, FranzBet al.: The role of singlet oxygen and oxygen concentration in photodynamic inactivation of bacteria.Proc. Natl Acad. Sci. USA104(17), 7223–7228 (2007).
  • Martin JP , LogsdonN: The role of oxygen radicals in dye-mediated photodynamic effects in Escherichia coli B.J. Biol. Chem.262(15), 7213–7219 (1987).
  • Hamblin MR , ZahraT, ContagCH, McManusAT, HasanT: Optical monitoring and treatment of potentially lethal wound infections in vivo.J. Infect. Dis.187(11), 1717–1726 (2003).
  • Ragas X , DaiT, TegosGP, AgutM, NonellS, HamblinMR: Photodynamic inactivation of Acinetobacter baumannii using phenothiazinium dyes: in-vitro and in-vivo studies.Lasers Surg. Med.42(5), 384–390 (2010).
  • Demidova TN , GadF, ZahraT, FrancisKP, HamblinMR: Monitoring photodynamic therapy of localized infections by bioluminescence imaging of genetically engineered bacteria.J. Photochem. Photobiol. B.81, 15–25 (2005).
  • Hamblin MR , DaiT: Can photodynamic therapy be used to treat surgical site infections?Photodiagn. Photodyn. Ther. (2010) (In press).
  • Endimiani A , LuzzaroF, BriganteGet al.: Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum β-lactamases.Antimicrob. Agents Chemother.49(7), 2598–2605 (2005).
  • Falcone M , PerilliM, MezzatestaMLet al.: Prolonged bacteraemia caused by vim-1 metallo-β-lactamase-producing Proteus mirabilis: first report from Italy.Clin. Microbiol. Infect.16(2), 179–181 (2010).
  • Lister PD : Chromosomally-encoded resistance mechanisms of pseudomonas aeruginosa: therapeutic implications.Am. J. Pharmacogenomics2(4), 235–243 (2002).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.